Skip to content
Dose Brief
Menu

Provider review

The Edit review: $259 sema, $349 tirzepatide

The Edit publishes a standing monthly rate and prepay rungs that divide correctly, names its pharmacy and its prescriber, and ships a full Spanish site.

By The Dose Brief Desk, News Editor

Updated · Editorial standards

In this brief

Provider prices and program details below reflect the September 1, 2026 source review. The October editorial correction does not refresh those quotes or independently verify current clinician or pharmacy credentials.

The Edit publishes both ongoing monthly prices and prepaid plan totals. Its first-order promotion is separate from the recurring charge, so the amount due after the introductory order is the useful starting point for budgeting. The dated prices below distinguish those options and their commitments. See The Edit provider profile for the summary and rating.

The standing rate is $259, not $200

Semaglutide is $259 a month. Tirzepatide is $349 a month. Those are the month-to-month rates, with no membership fee stacked on top and no minimum term, and they are what you pay from month two onward.1 The $200 and $300 figures the site leads with are a first-order promotion — disclosed as one, right beside the standing rate, but a first-month number all the same, and now set in larger type than the price you will actually pay. It is the teaser rate in a more assertive form than we found in August, when the standing rates were $209 and $309 and the promotion was a flat $100 off. Budget on $259.

The prepay math actually works

Three months of semaglutide is $575 billed once; six months is $1,065. Divide those out and you get $191.67 and $177.50 a month — the site rounds to $192 and $178 and labels both rungs "billed once at the start of the plan". Tirzepatide is $855 for three months ($285 a month) and $1,575 for six ($262.50, printed as $263). Every division lands where it should.

That reads like faint praise. It is not. The most common pricing error this wire corrects is a prepay rung printed as if it were a monthly rate — a number nobody can buy for one month, sitting at the top of a cheapest-first ranking. The Edit does not do it. Both columns are labeled, the billing cadence is stated, and the monthly rung is the one shown first. Anyone building a semaglutide price comparison can take these figures at face value.

The rest of the shelf

Six prescription protocols, five injectable and one cream: semaglutide, tirzepatide, NAD+ at $249 a month, glutathione at $199, sermorelin at $169, and GHK-Cu cream at $129.1 There is no oral GLP-1, no nasal line, no peptide sampler, and the site states outright that it does not sell research-use-only compounds. That last line is worth more than it looks: several providers in this cohort quietly stock compounds with no approval anywhere, retatrutide chief among them, and The Edit's catalog simply does not contain them.

Who is actually behind it

The corporate entity is The Edit Health LLC, a Texas management services organization in Austin. The medicine is practiced by Arora Health & Aesthetics, LLC, whose medical director is Dr. Sean Arora — NPI 1841729449, which we checked live against the federal NPPES registry and found active, family medicine, Seattle.2 The pharmacy is The Pharmacy Hub, named on the site rather than described as "our pharmacy partner". The intake and billing run on Bask Health.

Naming both the prescriber and the pharmacy puts The Edit ahead of most of the providers we read this month, and it is the second and third item on our own five-minute provider checklist for a reason: a provider that will not tell you who writes the script or who compounds the drug has decided that you do not need to know.

One overlap you should know about

The reviewed disclosures also name Sean Arora and Arora Health & Aesthetics for Trellis Vitality. The brands publish different pharmacies, prices and catalogs, but share a named clinical group. Do not assume they provide organizationally independent opinions; equally, the shared director does not prove you will see the same clinician.

Fees, refunds and the exit

Nothing is charged to start — the site says there is no charge and no card on file to begin, and a full refund is issued if a clinician does not approve you. A visit fee becomes non-refundable once a visit has actually happened, but none is taken up front, so there is no charge-regardless-of-outcome trap here. Compounded prescriptions are final sale once shipped, which is standard. Membership cancels at the end of the current period with no pro-rating, under a cancellation policy dated July 2026. The terms and help center both claim all 50 states, with address-level eligibility confirmed at the consultation — see how telehealth prescribing rules vary for why that last step exists.

The Spanish site is real

The Edit ships a complete Spanish mirror at /es/ — 33 Spanish URLs in its own sitemap, covering every page rather than a translated landing page and a dead end. Across the seven providers we researched in this batch, it is the only one with any Spanish surface at all.

What we could not check

We could not reach a checkout price. The Bask intake requires walking a questionnaire, and the JavaScript it loads carries framework code with no price table in it. So the ladder above is the published ladder, corroborated across two independent surfaces on the marketing site — not a figure confirmed at a card form. We say so rather than implying a stronger source than we have.

The regulatory screen

The August 2026 FDA warning-letter search did not identify company-name matches for the brand, legal entity, medical group or pharmacy.3 This limited, dated result is not FDA approval, proof of compliance or a complete current regulatory history.

Where it lands

The Edit is not cheap. At $259 and $349 it sits in the upper half of the rates on our semaglutide and tirzepatide wires, and if price is the only thing you are optimizing, Pepti at $109 and Trellis at $150 both undercut it heavily. What you are buying at the higher number is a price surface with nothing hidden in it, a named pharmacy, a verifiable prescriber and an exit you can take at the end of any month. Read it against the rest of the evidence library before you decide which of those you are actually paying for.

Frequently asked questions

How much does The Edit cost per month?

Semaglutide is $259 a month and tirzepatide is $349 a month, month-to-month, with no membership fee. Prepaying drops semaglutide to the equivalent of $192 a month over three months or $178 over six, and tirzepatide to $285 or $263 — but those plans are charged once at the start, not monthly.

Is the $200 first-month price real?

It is real for one month. The $200 semaglutide and $300 tirzepatide figures are a first-order promotion, disclosed as such next to the standing rates and printed larger than them. From month two you pay $259 and $349.

Does The Edit name its pharmacy?

Yes — The Pharmacy Hub, within what the site calls The Edit Health Pharmacy Network. It also names its medical director, Dr. Sean Arora, whose NPI is active in the federal NPPES registry.

Is The Edit the same company as Trellis Vitality?

Their disclosures name the same medical group and director, Arora Health & Aesthetics and Sean Arora, but the brands publish different pharmacies and prices. The shared group does not establish which clinician would treat you.

References

  1. The Edit Health (2026). Products and pricing. theedithealth.com. https://theedithealth.com/
  2. Centers for Medicare & Medicaid Services (2026). NPPES NPI Registry. npiregistry.cms.hhs.gov. https://npiregistry.cms.hhs.gov/
  3. U.S. Food and Drug Administration (2026). Warning Letters. FDA. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.